Company Performance Metrics
PET provide the PET centers with the radiopharmaceuticals, the project company will establish production of isotope 18O and organize two cyclotron sites—in Lipetsk and Ufa—for production of short-lived isotopes.
PET is used for the diagnosis of cancers, including diagnosis in early stages, and for diagnosis and treatment in cardiology and
neurology. Radiopharmaceuticals are selectively absorbed by tumor tissues and tissues whose metabolic activity is high. By combining into one instrument the functions of PET and computer tomography, benefits of both ensue—a three-dimensional picture of functional changes in tissue overlays a high-resolution image of the patient’s organs. PET diagnostics identify 18 percent more tumors in early stages, significantly improving prognoses and decreasing mortality.
